Literature DB >> 16680491

Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity.

D Boey1, S Lin, T Karl, P Baldock, N Lee, R Enriquez, M Couzens, K Slack, R Dallmann, A Sainsbury, H Herzog.   

Abstract

AIMS/HYPOTHESIS: Obese people exhibit reduced circulating peptide YY (PYY) levels, but it is unclear whether this is a consequence or cause of obesity. We therefore investigated the effect of Pyy ablation on energy homeostasis.
METHODS: Body composition, i.p. glucose tolerance, food intake and hypothalamic neuropeptide expression were determined in Pyy knock-out and wild-type mice on a normal or high-fat diet.
RESULTS: Pyy knock-out significantly increased bodyweight and increased fat mass by 50% in aged females on a normal diet. Male chow-fed Pyy (-/-) mice were resistant to obesity but became significantly fatter and glucose-intolerant compared with wild-types when fed a high-fat diet. Pyy knock-out animals exhibited significantly elevated fasting or glucose-stimulated serum insulin concentrations vs wild-types, with no increase in basal or fasting-induced food intake. Pyy knock-out decreased or had no effect on neuropeptide Y expression in the arcuate nucleus of the hypothalamus, and significantly increased proopiomelanocortin expression in this region. Male but not female knock-outs exhibited significantly increased growth hormone-releasing hormone expression in the ventromedial hypothalamus and significantly elevated serum IGF-I and testosterone levels. This sex difference in activation of the hypothalamo-pituitary somatotrophic axis by Pyy ablation may contribute to the resistance of chow-fed male knock-outs to late-onset obesity. CONCLUSIONS/
INTERPRETATION: PYY signalling is important in the regulation of energy balance and glucose homeostasis, possibly via regulation of insulin release. Therefore reduced PYY levels may predispose to the development of obesity, particularly with ageing or under conditions of high-fat feeding.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16680491     DOI: 10.1007/s00125-006-0237-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  37 in total

Review 1.  Effects of testosterone on body composition of the aging male.

Authors:  Shiyama Mudali; Adrian S Dobs
Journal:  Mech Ageing Dev       Date:  2004-04       Impact factor: 5.432

Review 2.  Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide.

Authors:  D Larhammar
Journal:  Regul Pept       Date:  1996-04-09

3.  c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action.

Authors:  Juan C Molero; Thomas E Jensen; Phil C Withers; Michelle Couzens; Herbert Herzog; Christine B F Thien; Wallace Y Langdon; Ken Walder; Maria A Murphy; David D L Bowtell; David E James; Gregory J Cooney
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

4.  Dietary obesity in nine inbred mouse strains.

Authors:  D B West; C N Boozer; D L Moody; R L Atkinson
Journal:  Am J Physiol       Date:  1992-06

5.  Effect of circulating peptide YY on gallbladder emptying in humans.

Authors:  F Hoentjen; W P Hopman; J B Jansen
Journal:  Scand J Gastroenterol       Date:  2001-10       Impact factor: 2.423

6.  Gut hormone PYY(3-36) physiologically inhibits food intake.

Authors:  Rachel L Batterham; Michael A Cowley; Caroline J Small; Herbert Herzog; Mark A Cohen; Catherine L Dakin; Alison M Wren; Audrey E Brynes; Malcolm J Low; Mohammad A Ghatei; Roger D Cone; Stephen R Bloom
Journal:  Nature       Date:  2002-08-08       Impact factor: 49.962

7.  Differential expression of mRNAs for neuropeptide Y-related peptides in rat nervous tissues: possible evolutionary conservation.

Authors:  V A Pieribone; L Brodin; K Friberg; J Dahlstrand; C Söderberg; D Larhammar; T Hökfelt
Journal:  J Neurosci       Date:  1992-09       Impact factor: 6.167

8.  PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet.

Authors:  Anita M van den Hoek; Annemieke C Heijboer; Eleonora P M Corssmit; Peter J Voshol; Johannes A Romijn; Louis M Havekes; Hanno Pijl
Journal:  Diabetes       Date:  2004-08       Impact factor: 9.461

9.  Inhibition of food intake in obese subjects by peptide YY3-36.

Authors:  Rachel L Batterham; Mark A Cohen; Sandra M Ellis; Carel W Le Roux; Dominic J Withers; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

10.  Effects of PYY[3-36] in rodent models of diabetes and obesity.

Authors:  R A Pittner; C X Moore; S P Bhavsar; B R Gedulin; P A Smith; C M Jodka; D G Parkes; J R Paterniti; V P Srivastava; A A Young
Journal:  Int J Obes Relat Metab Disord       Date:  2004-08
View more
  46 in total

1.  Endogenous PYY and GLP-1 mediate l-glutamine responses in intestinal mucosa.

Authors:  S Joshi; I R Tough; H M Cox
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

2.  NPY receptors as potential targets for anti-obesity drug development.

Authors:  Ernie Yulyaningsih; Lei Zhang; Herbert Herzog; Amanda Sainsbury
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

Review 3.  Fat sensing and metabolic syndrome.

Authors:  Jang H Youn
Journal:  Rev Endocr Metab Disord       Date:  2014-12       Impact factor: 6.514

Review 4.  Melanocortin neurons: Multiple routes to regulation of metabolism.

Authors:  Wen-Jie Shen; Ting Yao; Xingxing Kong; Kevin W Williams; Tiemin Liu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-05-09       Impact factor: 5.187

5.  Role of peptide YY(3-36) in the satiety produced by gastric delivery of macronutrients in rats.

Authors:  Roger Reidelberger; Alvin Haver; Prasanth K Chelikani
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-03-12       Impact factor: 4.310

6.  Relation of fasting plasma peptide YY to glucose metabolism and cardiovascular risk factors after restrictive bariatric surgery.

Authors:  Ursula Hanusch-Enserer; Mohammed A Ghatei; Edmund Cauza; Steven R Bloom; Rudolf Prager; Michael Roden
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

7.  Modulation of taste responsiveness by the satiation hormone peptide YY.

Authors:  Michael S La Sala; Maria D Hurtado; Alicia R Brown; Diego V Bohórquez; Rodger A Liddle; Herbert Herzog; Sergei Zolotukhin; Cedrick D Dotson
Journal:  FASEB J       Date:  2013-09-16       Impact factor: 5.191

8.  NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice.

Authors:  Yan-Chuan Shi; Shu Lin; Iris P L Wong; Paul A Baldock; Aygul Aljanova; Ronaldo F Enriquez; Lesley Castillo; Natalie F Mitchell; Ji-Ming Ye; Lei Zhang; Laurence Macia; Ernie Yulyaningsih; Amy D Nguyen; Sabrina J Riepler; Herbert Herzog; Amanda Sainsbury
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

9.  Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses.

Authors:  Helen M Cox; Iain R Tough; Anne-Marie Woolston; Lei Zhang; Amy D Nguyen; Amanda Sainsbury; Herbert Herzog
Journal:  Cell Metab       Date:  2010-06-09       Impact factor: 27.287

Review 10.  The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease.

Authors:  Gerwyn Morris; Michael Berk; Andre Carvalho; Javier R Caso; Yolanda Sanz; Ken Walder; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-06-27       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.